Christopher K Arnatt (Christopher Arnatt)

Publication Activity (10 Years)

Years Active: 2018-2022
Publications (10 Years): 4

Top Topics

Drug Administration

Estrogen Receptor

Top Venues

The Journal of organic chemistry

Journal of medical virology

Molecular pharmaceutics

ACS chemical neuroscience

This page only lists publications with an associated author ORCID identifier.

Publications

Chelsea DeLeon, Kyle Pemberton, Michael Green, Vanja Kalajdzic, Martina Rosato, Fenglian Xu, Christopher K Arnatt
Novel GPER Agonist, CITFA, Increases Neurite Growth in Rat Embryonic (E18) Hippocampal Neurons. ACS chemical neuroscience 13 (8) (2022)
Scott F Grady, Amelia K Pinto, Mariah Hassert, June A D'Angelo, James D Brien, Christopher K Arnatt
Selective estrogen receptor modulator, tamoxifen, inhibits Zika virus infection. Journal of medical virology 93 (11) (2021)
Anh S Lu, Milad Rouhimoghadam, Christopher K Arnatt, Edward J Filardo, Aliasger K Salem
Proteolytic Targeting Chimeras with Specificity for Plasma Membrane and Intracellular Estrogen Receptors. Molecular pharmaceutics 18 (3) (2021)
John T Petroff, Kristin N Skubic, Christopher K Arnatt, Ryan D McCulla
Asymmetric Dibenzothiophene Sulfones as Fluorescent Nuclear Stains. The Journal of organic chemistry 83 (22) (2018)